Aspirin and Retinitis - a phase IV clinical study of FDA data

Summary:

Retinitis is reported as a side effect among people who take Aspirin (aspirin), especially for people who are male, 60+ old, also take Revlimid, and have Acute lymphocytic leukemia (all).

The phase IV clinical study analyzes which people have Retinitis when taking Aspirin. It is created by eHealthMe based on reports of 622,087 people who have side effects when taking Aspirin from the FDA, and is updated regularly.

What is Aspirin?

Aspirin has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 632,088 Aspirin users. Check the latest studies of Aspirin.

What is Retinitis?

Retinitis (inflammation of the retina in the eye) is found to be associated with 229 drugs and 203 conditions by eHealthMe. Check the latest studies of Retinitis.

On Jul, 05, 2026

622,087 people reported to have side effects when taking Aspirin.
Among them, 24 people (0.0%) have Retinitis.

Among these 24 people:

What is the gender of people who have Retinitis when taking Aspirin? *

female: 20.83 %
male: 79.17 %

What is the age of people who have Retinitis when taking Aspirin? *

What are other drugs people take besides Aspirin? *

What are other side effects people have besides Retinitis? *

Uveitis (inflammation of the uvea): 16 people, 66.67%
Visual Acuity Reduced (reduced clearness of vision): 14 people, 58.33%
Pain: 14 people, 58.33%
Oedema Peripheral (superficial swelling): 14 people, 58.33%
Neuropathy Peripheral (surface nerve damage): 14 people, 58.33%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 13 people, 54.17%
Cataract (clouding of the lens inside the eye): 13 people, 54.17%
Osteomyelitis (infection of bone): 12 people, 50.00%
Kidney Stones: 12 people, 50.00%
Osteonecrosis Of Jaw (death of bone of jaw): 12 people, 50.00%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 2 people, 8.33%
Multiple Myeloma (cancer of the plasma cells): 2 people, 8.33%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 2 people, 8.33%
Myositis (inflammation of the muscles): 1 person, 4.17%
Insulin-Requiring Type 2 Diabetes Mellitus: 1 person, 4.17%
High Density Lipoprotein Decreased: 1 person, 4.17%
Gout (uric acid crystals building up in the body): 1 person, 4.17%
Behcet's Syndrome (involves inflammation of the blood vessels): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Aspirin and have Retinitis?

- Check whether Retinitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aspirin:

Aspirin (632,088 reports)

Retinitis treatments and more:

Retinitis (1,262 reports)

Browse all side effects of Aspirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Retinitis:

Retinitis (229 drugs)

Browse all the conditions that are associated with Retinitis:

Retinitis (203 conditions)

Related publications that referenced our studies

Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on aspirin (the active ingredients of Aspirin) and Aspirin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.